Vectura's Flutiform (fluticasone+formoterol) has failed in a phase 3 ... The company noted that there have been instances when other inhaled corticosteriod/long acting bronchodilator combinations ...

The Annals of Pharmacotherapy. 2009;43(3):519-527.

Objective: To review the basis for the estimated comparative daily dosages of inhaled corticosteroids for children and adults that are presented in the National Heart, Lung, and Blood Institute's ...

PMI reckons that by deploying Vectura's inhalation expertise and ... an asthma drug on the market called Flutiform (fluticasone propionate/ formoterol fumarate) which is sold by Mundipharma ...

Instead, all patients aged 12 and over should be offered a low dose combination inhaler of inhaled corticosteroid (ICS) and formoterol (a long acting β 2 agonist; LABA) to be taken as needed to reduce ...

Introduction and Objectives The Global Initiative for Asthma (GINA) endorse combination inhalers containing an inhaled corticosteroid (ICS) and a fast and long-acting beta-2 agonist (formoterol) as ...

In June, draft guidance published by NICE, BTS and SIGN revealed significant changes to the current treatment approaches, including replacing the use of short-acting beta agonist (SABA) alone with ...

All participants achieved PIF of ≥30 L/min before MC test. During bronchoconstriction the proportion was 97% in Salbutamol EH group and 100% in Budesonide-formoterol EH group. There was only a small ...

AstraZeneca’s Symbicort inhaler accounts for most of its inhalation ... a pMDI against a DPI for beclomethasone dipropionate plus formoterol fumarate to treat asthma found that the two methods ...

The study, led by MRINZ Director Professor Richard Beasley, found a 111% increase in budesonide/formoterol inhaler use among Māori in the last four years. “The findings highlight the high quality of ...